Taiwan eyes opportunities in precision medicine industry

Taiwan’s biotech and pharmaceutical industry was one of the first to be named in the original Tsai Administration’s 5+2 economic policy to transform the nation’s economic structure, and is viewed as the upcoming medical treatment trend that Taiwan cannot miss out on, said Johnsee Lee, the Honorary Chairman of Taiwan Bio Industry Organization (Taiwan BIO) during the Precision Medicine Industry Forum 2017 in Taipei, Wednesday.

Read the article in the Taiwan News.


發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *